Biomedical Engineering Reference
In-Depth Information
5. Aagaard L, and Rossi JJ. RNAi therapeutics: principles, prospects and
challenges.
(2-3):75-86.
6. Dykxhoorn DM, and Lieberman J. Knocking down disease with siRNAs.
Cell
Adv Drug Deliv Rev
, 2007;
59
(2):231-235.
7. Dykxhoorn DM, and Lieberman J. Running interference: prospects and
obstacles to using small interfering RNAs as small molecule drugs.
Annu Rev Biomed Eng
., 2006;
126
:377-402.
8. Peer D, Park EJ, Morishita Y, Carman CV, and Shimaoka M. Systemic
leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-
inflammatory target.
, 2006;
8
(5863):627-630.
9. Elfakess R, and Peer D. Overcoming RNAi transduction in leukocytes
using targeted and stabilized nanoparticles.
Science
, 2008;
319
IDrugs
, 2010;
13
(9):
626-631.
10. Goldsmith M, Mizrahy S, and Peer D. Grand challenges in modulating
the immune response with RNAi nanomedicines.
Nanomedicine
(10):1771-1785.
11. Ben-Arie N, Kedmi R, and Peer D. Integrin-targeted nanoparticles for
siRNA delivery.
(
Lond
), 2011;
6
:497-507.
12. Huang Z, and King MR. An immobilized nanoparticle-based platform
for efficient gene knockdown of targeted cells in the circulation.
Methods Mol Biol
, 2012;
757
Gene
(10):1271-1282.
13. Eguchi A, Meade BR, Chang YC, Fredrickson CT, Willert K, Puri N,
Ther
, 2009;
16
.
Efficient siRNA delivery into primary cells by a peptide transduction
domain-dsRNA binding domain fusion protein.
et al
Nat Biotechnol
, 2009;
(6):567-571.
14. Zhou J, Swiderski P, Li H, Zhang J, Neff CP, Akkina R,
27
. Selection,
characterization and application of new RNA HIV gp 120 aptamers for
facile delivery of dicer substrate siRNAs into HIV infected cells.
et al
Nucleic
(9):3094-3109.
15. Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski
M,
Acids Res
, 2009;
37
delivery of siRNA to immune cells by conjugation to a
TLR9 agonist enhances antitumor immune responses.
et al
.
In vivo
Nat Biotechnol
,
(10):925-932.
16. Ishimoto T, Takei Y, Yuzawa Y, Hanai K, Nagahara S, Tarumi Y,
2009;
27
.
Downregulation of monocyte chemoattractant protein-1 involving
short interfering RNA attenuates hapten-induced contact hyper-
sensitivity.
et al
(2):387-395.
17. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL,
Mol Ther
, 2008;
16
. T cell-
specific siRNA delivery suppresses HIV-1 infection in humanized mice.
Cell
et al
, 2008;
134
(4):577-586.
Search WWH ::
Custom Search